ARCHIVES

Three Studies Test Oncotype DX In Breast and Colon Cancers

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981

DCE Board Approves Epidemiology Contract Recompetitions

March 17, 1995

NCA Asks HHS To Exempt From DRG Peer Reviewed Institutions With At Least 25 Protocol Patients

August 12, 1983

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

July 10, 1992

NCI Funds Proteomic Technology Assessment Grants.

September 29, 2006